These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11476461)

  • 1. Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study.
    Obase Y; Shimoda T; Tomari S; Mitsuta K; Fukushima C; Kawano T; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Jul; 87(1):43-7. PubMed ID: 11476461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study.
    Obase Y; Shimoda T; Matsuse H; Kondo Y; Machida I; Kawano T; Saeki S; Tomari S; Mitsuta-Izaki K; Matsuo N; Fukushima C; Kohno S
    Respiration; 2004; 71(3):225-32. PubMed ID: 15133341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of response to long-term treatment with Pranlukast in patients with bronchial asthma.
    Niitsuma T; Izawa J; Maruoka N; Nukaga M; Tsuji A; Okita M; Sakurai K; Morita S; Tsuyuguchi M; Matsumura Y; Hayashi T
    J Investig Allergol Clin Immunol; 2004; 14(4):284-91. PubMed ID: 15736713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
    Yoo SH; Park SH; Song JS; Kang KH; Park CS; Yoo JH; Choi BW; Hahn MH;
    Respirology; 2001 Mar; 6(1):15-21. PubMed ID: 11264758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma.
    Kohrogi H; Iwagoe H; Fujii K; Hamamoto J; Fukuda K; Hirata N; Kawano O; Matsumoto M; Suga M; Ando M
    Respirology; 1999 Sep; 4(3):319-23. PubMed ID: 10489683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Shiga M; Hirose M; Ito T
    Arzneimittelforschung; 2003; 53(10):714-21. PubMed ID: 14650364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist.
    Grossman J; Faiferman I; Dubb JW; Tompson DJ; Busse W; Bronsky E; Montanaro A; Southern L; Tinkelman D
    J Asthma; 1997; 34(4):321-8. PubMed ID: 9250256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.
    Yokoyama A; Kohno N; Sakai K; Hirasawa Y; Kondo K; Hiwada K
    J Asthma; 1998; 35(1):57-62. PubMed ID: 9513583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma.
    Oosaki R; Mizushima Y; Kashii T; Kawasaki A; Kobayashi M
    Int Arch Allergy Immunol; 1997 Sep; 114(1):97-100. PubMed ID: 9303339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist.
    Nakasato H; Ohrui T; Sekizawa K; Matsui T; Yamaya M; Tamura G; Sasaki H
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):585-8. PubMed ID: 10482831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha.
    Tanaka H; Saito T; Kurokawa K; Teramoto S; Miyazaki N; Kaneko S; Hashimoto M; Abe S
    Allergy; 1999 May; 54(5):489-94. PubMed ID: 10380781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor.
    Terashima T; Amakawa K; Matsumaru A; Yamaguchi K
    Chest; 2002 Nov; 122(5):1566-70. PubMed ID: 12426254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
    Nakamura Y; Hoshino M; Sim JJ; Ishii K; Hosaka K; Sakamoto T
    Thorax; 1998 Oct; 53(10):835-41. PubMed ID: 10193369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast.
    Yanagawa H; Sugita A; Azuma M; Ogawa H; Kitamuro C; Yoneda K; Shinkawa K; Tani K; Sone S
    Lung; 2004; 182(1):51-8. PubMed ID: 14752672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.